Wall Street Analysts Think Adverum Biotechnologies (ADVM) Could Surge 290.54%: Read This Before Placing a BetZacks Investment Research • 07/16/24
Down -19.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)Zacks Investment Research • 05/10/24
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline HighlightsGlobeNewsWire • 05/09/24
Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 05/02/24
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific MeetingGlobeNewsWire • 04/25/24
Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 04/23/24
Down -24.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)Zacks Investment Research • 04/19/24
Are Medical Stocks Lagging Adverum Biotechnologies (ADVM) This Year?Zacks Investment Research • 04/04/24
Down -28.72% in 4 Weeks, Here's Why Adverum Biotechnologies (ADVM) Looks Ripe for a TurnaroundZacks Investment Research • 04/03/24
Down -29.25% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)Zacks Investment Research • 03/27/24
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate UpdatesGlobeNewsWire • 03/18/24
Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care ConferenceGlobeNewsWire • 02/28/24
Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceGlobeNewsWire • 02/12/24
Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMDGlobeNewsWire • 02/08/24
Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024GlobeNewsWire • 02/01/24
Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific OfficerGlobeNewsWire • 01/29/24
Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meeting of the Macula SocietyGlobeNewsWire • 12/07/23
Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx ConferenceGlobeNewsWire • 11/28/23